Esteri Cetilici (Oral)
Osteoarthritis, Joint Mobility
Key Facts
About Pharmanutra
Pharmanutra's mission is to advance nutraceutical science by developing clinically-proven, high-quality food supplements and medical devices. Its key achievement is building a defensible commercial portfolio anchored by its patented Sucrosomial® and Esteri Cetilici delivery technologies, which are supported by a growing body of peer-reviewed research. The company's strategy focuses on generating robust clinical data to differentiate its products, expanding its international footprint from its strong Italian base, and leveraging its R&D pipeline to address nutritional deficiencies and functional support across multiple therapeutic areas. Pharmanutra's public listing provides capital for this focused growth strategy.
View full company profile